Table 4 Association between ESBL phenotype and Enterobacteriaceae isolated, sample type and susceptibility pattern
ESBL (%) | Non-ESBL (%) | P value | |
|---|---|---|---|
Isolate | |||
E. coli | 36 (58.1) | 26 (41.9) | 0.924 |
Klebsiella pneumoniae | 24 (72.7) | 9 (27.3) | 0.908 |
Enterobacter cloacae | 1 (25) | 3 (75) | 0.695 |
Proteus mirabilis | 10 (62.5) | 6 (37.5) | 0.999 |
Sample type | |||
Urine | 46 (63.9) | 26 (36.1) | 0.980 |
HVS | 6 (54.5) | 5 (45.5) | 0.999 |
CSF | 1 (100) | 0 (0) | 0.999 |
Urethral swab | 1 (100) | 0 (0) | 1.000 |
Wound swab | 2 (100) | 0 (0) | 1.000 |
Blood | 2 (40) | 3 (60) | 1.000 |
Pus swab | 9 (47.4) | 10 (52.6) | 0.999 |
Surgical wound swab | 4 (100) | 0 (0) | 0.999 |
Ceftazidime Susceptibility | |||
Resistant | 62 (73.8) | 22 (26.2) | 0.408 |
Intermediate | 4 (36.4) | 7 (63.6) | 0.187 |
Susceptible | 5 (25) | 15 (75) | 0.480 |
Cefotaxime Susceptibility | |||
Resistant | 54 (81.8) | 12 (18.2) | 0.013 |
Intermediate | 4 (30.8) | 9 (69.2) | 0.067 |
Susceptible | 13 (36.1) | 23 (63.9) | 0.430 |
Binomial logistic regression |